Yonglin Pu

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Ejection Fraction

Smoking Cessation

Top Venues

European journal of hybrid imaging

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan A Trujillo, James K Godfrey, Yifei Hu, Jun Huang, Sonali M Smith, Matthew J Frigault, Zachariah DeFilipp, Daniel Appelbaum, Yonglin Pu, Nicholas Feinberg, Thomas Althaus, Michael R Bishop, Peter A Riedell, Justin Kline
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma. Blood 137 (24) (2021)
Yonglin Pu, James X Zhang, Haiyan Liu, Daniel Appelbaum, Jianfeng Meng, Bill C Penney
Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging. European journal of nuclear medicine and molecular imaging 45 (12) (2018)
Brittany Z Dashevsky, Chenpeng Zhang, Li Yan, Cindy Yuan, Lingyun Xiong, Yongmei Liu, Haiyan Liu, Feng-Ming Spring Kong, Yonglin Pu
Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation. European journal of hybrid imaging 1 (1) (2017)